Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Varrone

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 21, 2020
Simplified quantification of [<sup>18</sup>F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibriumJoachim Brumberg, Vera Kerstens, Zsolt Cselényi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2018
PET imaging of [<sup>11</sup>C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter bindingKatarina Varnäs, Zsolt Cselényi, Aurelija Jucaite, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of presynaptic dopaminergic imaging with <sup>123</sup>I-ioflupane and noradrenergic imaging with <sup>123</sup>I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development frameworkIda Sonni, Osman Ratib, Marina Boccardi, et al.
Plos One|May 22, 2015
Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of NeuroinflammationMiklós Tóth, Janine Doorduin, Jenny Häggkvist, et al.
Science (New York, N.Y.)|February 7, 2009
Changes in cortical dopamine D1 receptor binding associated with cognitive trainingFiona McNab, Andrea Varrone, Lars Farde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2012
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRTMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2003
Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activitiesKyeong Min Kim, Andrea Varrone, Hiroshi Watabe, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|April 3, 2019
Synthesis, <sup>3</sup> H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2Markus Artelsmair, Patricia Miranda-Azpiazu, Lee Kingston, et al.
Synapse (New York, N.Y.)|November 30, 2011
In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligandSangram Nag, Andrea Varrone, Miklós Tóth, et al.
Neuroimage|January 13, 2009
[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenilIkuo Odano, Christer Halldin, Per Karlsson, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 21, 2020
Simplified quantification of [<sup>18</sup>F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibriumJoachim Brumberg, Vera Kerstens, Zsolt Cselényi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 2, 2018
PET imaging of [<sup>11</sup>C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter bindingKatarina Varnäs, Zsolt Cselényi, Aurelija Jucaite, et al.
Neurobiology of Aging|March 21, 2017
Clinical validity of presynaptic dopaminergic imaging with <sup>123</sup>I-ioflupane and noradrenergic imaging with <sup>123</sup>I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development frameworkIda Sonni, Osman Ratib, Marina Boccardi, et al.
Plos One|May 22, 2015
Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of NeuroinflammationMiklós Tóth, Janine Doorduin, Jenny Häggkvist, et al.
Science (New York, N.Y.)|February 7, 2009
Changes in cortical dopamine D1 receptor binding associated with cognitive trainingFiona McNab, Andrea Varrone, Lars Farde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2012
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRTMartin Schain, Miklós Tóth, Zsolt Cselényi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2003
Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activitiesKyeong Min Kim, Andrea Varrone, Hiroshi Watabe, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|April 3, 2019
Synthesis, <sup>3</sup> H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2Markus Artelsmair, Patricia Miranda-Azpiazu, Lee Kingston, et al.
Synapse (New York, N.Y.)|November 30, 2011
In vivo evaluation in cynomolgus monkey brain and metabolism of [¹⁸F]fluorodeprenyl: a new MAO-B pet radioligandSangram Nag, Andrea Varrone, Miklós Tóth, et al.
Neuroimage|January 13, 2009
[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenilIkuo Odano, Christer Halldin, Per Karlsson, et al.
Pageof 17